It has already been suggested that, besides the classical antiangiogenic effect of endostatin, a second mechanism may also be implied in endostatin-dependent tumor regression, associated with tumor infiltration of leucocytes promoted by leukocyte-endothelium interactions, indicating that a combination of both these effects leads to tumor regression [19,20]. Here, COL18A1 is linked to neoplasm.